May - 2021
Previous Next | Showing Journal 6 of 10 |
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19The REMAP-CAP Investigators New Eng J Med, 2021, 384:1491-1502 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
May |
Previous Comments
No Comments yet.
Comment
This study comes from the Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP) investigators.
REMAP-CAP is an international, adaptive...